Description: ObsEva SA is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics for woman's reproductive health and pregnancy. ObsEva SA is headquartered in Geneva, Switzerland.
Home Page: www.obseva.com
OBSV Technical Analysis
Chemin des Aulx, 12
Geneva,
1228
Switzerland
Phone:
41 22 552 38 40
Officers
| Name | Title |
|---|---|
| Mr. Brian O'Callaghan | CEO & Director |
| Dr. Ernest Loumaye M.D., OB/GYN, Ph.D. | Co-Founder & Director |
| Mr. Fabien Lefebvre de Ladonchamps | Chief Admin. Officer |
| Mr. Clive Bertram | Chief Commercial Officer |
| Mr. Luigi Marro | Chief Transformation Officer |
| Mr. William Michael Brown | Chief Financial Officer |
| Ms. Delphine Renaud | Personal Assistant to the CSO and Head of R&D |
| Ms. Katja Buhrer | Chief Strategy Officer |
| Ms. Brandi Howard Ph.D. | Chief Clinical Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7249 |
| Price-to-Sales TTM: | 4.0246 |
| IPO Date: | 2017-01-26 |
| Fiscal Year End: | December |
| Full Time Employees: | 48 |